IGF1 and acne: Decreased probiotics in the intestinal tract of acne vulgaris patients, reduce microbial Trp metabolites which would otherwise alleviate both innate and adaptive immune inflammation, downregulating insulin and IGF-1/mTORC1 signaling, promoting the AhR inhibition of sebum production and enhancing intestinal mucosa stability.